Il y a eu 50 transactions d'initiés récentes enregistrées pour Mind Medicine (MindMed) Inc. (MNMD), dont 26 achats et 22 ventes. Le total des achats d'initiés s'élève à $14.47M et le total des ventes d'initiés à $1.75M.
Les initiés notables ayant une activité récente comprennent Sullivan Mark, Barrow Robert, Karlin Daniel. Les transactions d'initiés peuvent fournir des indications sur la façon dont la direction perçoit la valorisation et les perspectives futures de l'action.
Transactions d'Initiés — MNMD
| Date |
Nom |
Rôle |
Type de Transaction |
Actions |
Prix Moyen |
Valeur |
Actions détenues |
| 2025-06-25 |
Sullivan Mark |
Chief Legal Officer |
Vente Informative |
11,491 |
$6.80 |
$78.14K |
305,130 |
| 2025-06-25 |
Barrow Robert |
Chief Executive Officer |
Vente Informative |
26,491 |
$6.80 |
$180.14K |
830,065 |
| 2025-06-25 |
Karlin Daniel |
Chief Medical Officer |
Vente Informative |
7,848 |
$6.80 |
$53.37K |
438,329 |
| 2025-06-12 |
Gryska David W |
Director |
Attribution de RSU |
75,187 |
$7.30 |
$548.87K |
75,187 |
| 2025-06-12 |
Vallone Carol A |
Director |
Attribution de RSU |
75,187 |
$7.30 |
$548.87K |
75,187 |
| 2025-06-12 |
Krebs Andreas |
Director |
Attribution de RSU |
75,187 |
$7.30 |
$548.87K |
75,187 |
| 2025-06-12 |
Bruhn Suzanne Louise |
Director |
Attribution de RSU |
75,187 |
$7.30 |
$548.87K |
75,187 |
| 2025-06-12 |
Crystal Roger |
Director |
Attribution de RSU |
75,187 |
$7.30 |
$548.87K |
75,187 |
| 2025-06-02 |
Roberts Brandi |
Officer |
Inconnu |
- |
- |
- |
- |
| 2025-06-02 |
Roberts Brandi |
Chief Financial Officer |
Attribution de RSU |
500,000 |
$7.26 |
$3.63M |
500,000 |
| 2025-03-25 |
Sullivan Mark |
Chief Legal Officer |
Vente Informative |
6,576 |
$6.74 |
$44.32K |
316,621 |
| 2025-03-25 |
Barrow Robert |
Chief Executive Officer |
Vente Informative |
21,208 |
$6.74 |
$142.94K |
856,556 |
| 2025-03-25 |
Karlin Daniel |
Chief Medical Officer |
Vente Informative |
6,836 |
$6.74 |
$46.07K |
446,177 |
| 2025-03-25 |
Liao Carrie |
Chief Accounting Officer |
Vente Informative |
2,347 |
$6.74 |
$15.82K |
144,923 |
| 2025-03-17 |
Wiley Matthew T. |
Officer |
Inconnu |
- |
- |
- |
- |
| 2025-03-17 |
Wiley Matthew T. |
Chief Commercial Officer |
Attribution de RSU |
350,000 |
$6.35 |
$2.22M |
350,000 |
| 2025-03-12 |
Sullivan Mark |
Chief Legal Officer |
Attribution de RSU |
150,000 |
- |
- |
323,197 |
| 2025-03-12 |
Barrow Robert |
Chief Executive Officer |
Attribution de RSU |
350,000 |
- |
- |
877,764 |
| 2025-03-12 |
Karlin Daniel |
Chief Medical Officer |
Attribution de RSU |
115,000 |
- |
- |
453,013 |
| 2025-03-12 |
Liao Carrie |
Chief Accounting Officer |
Attribution de RSU |
50,000 |
- |
- |
142,270 |
| 2024-12-26 |
Sullivan Mark |
Chief Legal Officer |
Vente Informative |
4,519 |
$7.43 |
$33.58K |
173,197 |
| 2024-12-26 |
Barrow Robert |
Chief Executive Officer |
Vente Informative |
19,106 |
$7.43 |
$141.96K |
526,666 |
| 2024-12-26 |
Karlin Dan |
Chief Medical Officer |
Vente Informative |
6,643 |
$7.43 |
$49.36K |
338,013 |
| 2024-12-26 |
Liao Carrie |
Chief Accounting Officer |
Vente Informative |
2,273 |
$7.43 |
$16.89K |
97,270 |
| 2024-12-05 |
Gryska David W |
Director |
Achat Informatif |
2,500 |
$7.17 |
$17.93K |
19,851 |
| 2024-09-25 |
Sullivan Mark |
Chief Legal Officer |
Vente Informative |
4,430 |
$5.98 |
$26.49K |
177,716 |
| 2024-09-25 |
Barrow Robert |
Chief Executive Officer |
Vente Informative |
19,771 |
$5.98 |
$118.23K |
545,772 |
| 2024-09-25 |
Karlin Dan |
Chief Medical Officer |
Vente Informative |
6,871 |
$5.98 |
$41.09K |
344,656 |
| 2024-09-25 |
Liao Carrie |
Chief Accounting Officer |
Vente Informative |
2,352 |
$5.98 |
$14.06K |
99,543 |
| 2024-08-23 |
Gryska David W |
Director |
Achat Informatif |
3,500 |
$5.98 |
$20.93K |
17,351 |
| 2024-08-21 |
Halperin Wernli Miri |
Executive President |
Exercice d'Options (Vente) |
50,000 |
$3.70 |
$185K |
- |
| 2024-08-20 |
Barrow Robert |
Chief Executive Officer |
Achat Informatif |
500 |
$6.12 |
$3.06K |
565,543 |
| 2024-08-19 |
Barrow Robert |
Chief Executive Officer |
Achat Informatif |
500 |
$6.31 |
$3.16K |
565,043 |
| 2024-06-25 |
Sullivan Mark |
Chief Legal Officer |
Vente Informative |
17,854 |
$7.22 |
$128.91K |
182,146 |
| 2024-06-25 |
Barrow Robert |
Chief Executive Officer |
Vente Informative |
15,659 |
$7.22 |
$113.06K |
564,543 |
| 2024-06-25 |
Karlin Dan |
Chief Medical Officer |
Vente Informative |
6,925 |
$7.22 |
$50K |
351,527 |
| 2024-06-10 |
Gryska David W |
Director |
Attribution de RSU |
16,506 |
$7.25 |
$119.67K |
16,506 |
| 2024-06-10 |
Vallone Carol A |
Director |
Attribution de RSU |
16,506 |
$7.25 |
$119.67K |
16,506 |
| 2024-06-10 |
Krebs Andreas |
Director |
Attribution de RSU |
16,506 |
$7.25 |
$119.67K |
16,506 |
| 2024-06-10 |
Bruhn Suzanne Louise |
Director |
Attribution de RSU |
16,506 |
$7.25 |
$119.67K |
16,506 |
| 2024-06-10 |
Crystal Roger |
Director |
Attribution de RSU |
16,506 |
$7.25 |
$119.67K |
16,506 |
| 2024-03-25 |
Greenway Schond L. |
Chief Financial Officer |
Retenue Fiscale RSU |
5,560 |
$9.78 |
$54.38K |
211,057 |
| 2024-03-25 |
Barrow Robert |
Chief Executive Officer |
Vente Informative |
16,519 |
$9.50 |
$156.93K |
580,202 |
| 2024-03-25 |
Karlin Dan |
Chief Medical Officer |
Vente Informative |
6,578 |
$9.50 |
$62.49K |
358,452 |
| 2024-02-27 |
Sullivan Mark |
Chief Legal Officer |
Attribution de RSU |
125,000 |
$4.98 |
$622.5K |
125,000 |
| 2024-02-27 |
Greenway Schond L. |
Chief Financial Officer |
Attribution de RSU |
150,000 |
$4.98 |
$747K |
150,000 |
| 2024-02-27 |
Barrow Robert |
Chief Executive Officer |
Attribution de RSU |
400,000 |
$4.98 |
$1.99M |
400,000 |
| 2024-02-27 |
Wernli Miri Halperin |
Executive President |
Attribution de RSU |
125,000 |
$4.98 |
$622.5K |
125,000 |
| 2024-02-27 |
Karlin Dan |
Chief Medical Officer |
Attribution de RSU |
150,000 |
$4.98 |
$747K |
150,000 |
| 2024-02-27 |
Liao Carrie |
Chief Accounting Officer |
Attribution de RSU |
100,000 |
$4.98 |
$498K |
100,000 |
■ Informatif — transaction sur marché ouvert (la plus significative)
■ Non informatif (achat) — récompense, exercice d'option, conversion
■ Non informatif (vente) — retenue fiscale, vente à l'acquisition
■ Neutre — don, fiducie, expiration
Les autres consultent aussi
